As techniques evolve that allow molecular characterization of disease proce
sses such as cancer, definition of "normal" at a molecular level becomes in
creasingly important. Increasingly large numbers of mutations are found at
the genomic level, but whether all of those mutations contribute to the mal
ignant state of a carcinoma cell is not clear. Without knowledge of what co
nstitutes normality on the proteomic level in an organ or cell, we cannot d
etermine what genomic changes are physiologically important. Traditionally,
colon cancer is identified and classified by histological criteria. Margin
s of the colon are defined as "grossly uninvolved" when the histology is in
distinguishable from that of normal (free from disease) colon. By using mol
ecular pathology techniques and working backward from colon adenocarcinoma
to hypoplastic polyps to presumably normal mucosa, we defined some of those
protein differences. Our results may provide a molecular basis for identif
ying tumor formation and progression in situ.